Should future research elucidate the protein product of the C20orf165 gene and identify it as a viable target for inhibition due to its role in important biochemical pathways, the development of inhibitors would begin with the determination of its structure and function. Advanced techniques such as X-ray crystallography, NMR spectroscopy, or cryo-electron microscopy may be used to understand the three-dimensional conformation of the protein. This structural knowledge would be essential for the identification of potential active sites or allosteric sites that could be targeted by small molecules or other inhibitory compounds. A detailed understanding of the protein's mechanism of action would also be crucial, as this would provide insights into how the binding of an inhibitor might influence the protein's activity within the cell.
Once the target sites on the protein are identified, the discovery of potential C20orf165 inhibitors would typically involve high-throughput screening of diverse chemical libraries to find molecules that can bind to the protein with sufficient affinity. Hits from these screens would then be optimized through medicinal chemistry efforts, guided by structure-activity relationship (SAR) studies. Chemists would synthesize a series of analogs, methodically modifying the chemical structure of initial hits to enhance their potency, specificity, and overall physicochemical properties as inhibitors. Computational chemistry techniques, including molecular modeling and docking simulations, would complement empirical testing by predicting how different chemical modifications might affect the interaction with the protein. Ultimately, if successful, this process would yield a collection of molecules that effectively inhibit the activity of the C20orf165 protein, providing valuable tools for understanding its function and role in cellular biology.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A is a histone deacetylase inhibitor which can alter chromatin structure and broadly affect gene expression patterns, potentially downregulating SPATA25. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
Vorinostat, another histone deacetylase inhibitor, may change the expression of genes by affecting chromatin accessibility and modifying histone acetylation. | ||||||
MS-275 | 209783-80-2 | sc-279455 sc-279455A sc-279455B | 1 mg 5 mg 25 mg | $24.00 $90.00 $212.00 | 24 | |
Entinostat is a selective histone deacetylase inhibitor that can modify gene expression through chromatin remodeling, influencing various genes including possibly SPATA25. | ||||||
Romidepsin | 128517-07-7 | sc-364603 sc-364603A | 1 mg 5 mg | $218.00 $634.00 | 1 | |
Romidepsin is a histone deacetylase inhibitor used to alter the expression of genes by impacting the acetylation state of histones, which could include SPATA25. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Sodium butyrate is a short-chain fatty acid that serves as an inhibitor of histone deacetylase, influencing gene expression across many cellular pathways. | ||||||
Mithramycin A | 18378-89-7 | sc-200909 | 1 mg | $55.00 | 6 | |
Mithramycin A binds to DNA and inhibits transcription factor binding, leading to altered gene expression profiles, including potential suppression of SPATA25. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG, a polyphenol found in green tea, has been reported to modulate gene expression and has potential anti-cancer properties that might affect SPATA25 expression. | ||||||
Disulfiram | 97-77-8 | sc-205654 sc-205654A | 50 g 100 g | $53.00 $89.00 | 7 | |
Disulfiram can inhibit acetaldehyde dehydrogenase and has been shown to modulate the proteasome pathway, potentially affecting protein levels including SPATA25. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid, a metabolite of vitamin A, acts as a ligand for nuclear receptors and can regulate gene expression. It may affect the expression of genes involved in spermatogenesis. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor that can alter cell signaling pathways and may result in changes in gene expression, including genes related to spermatogenesis. | ||||||